J NEUROL 润色咨询

JOURNAL OF NEUROLOGY

出版年份:1974 年文章数:4000 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2021-04-01 ms9000001571807559

    请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2022-11-02 隐形的翅膀

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊

    12

    展开12条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2024-01-08 阿杰11 来自黑龙江省

    求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2023-06-28 CottonBlue 来自湖北省

    审稿速度:1.0
    经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2023-11-27 ms7000001113449944 来自海南省

    请问纯临床接受吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2014-09-29 bingojean

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。
    而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2019-05-21 Janzu2003

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2018-08-27 ms5469518383470847

    审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2023-06-20 ms5000000540226119 来自江苏省

    老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神,这个杂志接受基础性的研究还是临床类型的研究?谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:神经性肌病临床实验文章投稿。2022-9-6号投稿,2022-10-3一审意见回来,3个审稿人,大大小小接近80多个问题,有些问题非常雕专,日夜兼程的改了1个月,2022-11-1上午11:40返修回去,2022-11-1下午 14:24显示accepted,竟然只用来3个小时,返修后编辑就直接审稿拍板接收了,这速度简直惊人的让人五体投地。这个杂志是老牌期刊,拒稿率90%以上,之前被秒拒过,这次有幸被接受,太激动,新的IF=6.67,逐年上升,搞不好,明年可以冲到8分,很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问,为什么 s u b m i t t e d t o j o u r n a l好几天了,还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0<br>经验分享:编辑非常高效,按照编辑给的意见修改,大修后直接接受,没有多余的废话,整体审稿时间一个月,非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:编辑提供的拒稿率为90%,拒稿没有意见,编辑不要就是不要。你没治。 <br> 而且所属Springer的投稿要求很不清楚,需要反复与投稿系统的助理沟通,大家有需要的可以问我怎么投,过来人了。。。在这里攒人品,希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571245, encodeId=4dd75e1245d7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:4月27日初次投稿,4月30日返修格式(投稿成功),5月12日审稿结束,大修(其实是小修),两个审稿人,均表示有兴趣,一个提出了点论文局限性,另一个提出的两个问题,手稿中均已阐述清楚。偷懒一个星期,5月19日晚修回,次日中午with editor,晚上接收。 这个文章,我试着投了很多高分杂志(包含柳叶刀、jama、BMJ等),大多秒拒,骗回了BMJ的审稿意见,后面觉得虽然题目很好,但是确实存在某无法避免的缺陷,就随便找了个杂志投,没想到,这么顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b97975802, createdName=Janzu2003, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846694, encodeId=e1ad84669437, content=审稿一个月,大修认真按审稿人的意见修改,文章接收后面一系列的程序都很快,效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Mon Aug 27 22:42:36 CST 2018, time=2018-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143815, encodeId=a7c2214381594, content=老牌杂志,历史极为悠久,1891年开刊,虽然是二区但是要求和审稿丝毫不弱于Neurology和Brain等一众顶刊,但好在其审稿决定迅速,即便是Reject也不会耽误作者太多时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Tue Jun 20 08:27:08 CST 2023, time=2023-06-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=585569, encodeId=b11e5855697a, content=投稿命中率:25.0<br>经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0df95263922, createdName=1480aa6cm65(暂无昵称), createdTime=Fri Feb 28 23:23:00 CST 2020, time=2020-02-28, status=1, ipAttribution=)]
    2020-02-28 1480aa6cm65(暂无昵称)

    投稿命中率:25.0
    经验分享:是神内的综合类杂志。官网上有明确的审稿周期,很快。投了一篇微出血,建议改投其他专门的脑血管疾病的杂志。(2020.2.2.22投,2.24拒,但是会推荐同一家出版社的其他杂志。推荐杂志2-3天之后发过来)

    4

    展开4条回复
共108条页码: 1/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分